Related Experiment Video
Updated: Jul 13, 2026

Surgical Porcine Model of Chronic Myocardial Ischemia Treated by Exosome-laden Collagen Patch and Off-pump Coronary Artery Bypass Graft
Published on: September 15, 2023
Survival after percutaneous coronary intervention and coronary artery bypass grafting in a single centre
1Feiring Heart Clinic, Feiring, N-2093 Norway. moelsta@online.no
Insights
Coronary artery bypass grafting (CABG) significantly improves survival in patients with three-vessel coronary disease, regardless of diabetes. Percutaneous coronary intervention (PCI) showed no survival benefit in most cases.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Cardiac Surgery
Background:
- Coronary artery disease (CAD) management involves revascularization strategies like percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG).
- Optimal treatment selection for CAD patients, particularly those with complex disease patterns, remains a critical clinical decision.
Purpose of the Study:
- To compare the long-term survival rates of patients undergoing PCI versus CABG for coronary artery disease.
- To evaluate the impact of disease severity (number of diseased vessels) and diabetes on treatment outcomes.
Main Methods:
- A retrospective analysis of 10,815 patients (6366 PCI, 4449 CABG) treated between March 1999 and December 2005.
- Survival status was tracked via the Norwegian National Registry up to May 2006.
- Statistical comparison utilized Cox regression and propensity score analysis to adjust for covariates.
Main Results:
- Coronary artery bypass grafting (CABG) demonstrated significantly improved survival compared to percutaneous coronary intervention (PCI) in patients with three-vessel disease (hazard ratios 0.40 with diabetes, 0.61 without).
- A borderline significant survival difference favoring CABG was noted in patients with one/two-vessel disease and diabetes.
- No significant survival difference was observed between PCI and CABG in patients with one/two-vessel disease without diabetes.
Conclusions:
- Coronary artery bypass grafting (CABG) appears to offer a survival advantage over percutaneous coronary intervention (PCI) for patients with three-vessel coronary artery disease, including those with diabetes.
- Treatment strategy decisions should consider the extent of coronary artery disease and patient comorbidities.
Objectives:
Comparison of survival after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in patients with coronary disease.
Design:
Feiring Heart Clinic treated 10 815 patients with a coronary intervention (6366 PCI, 4449 CABG) from March 1999 to December 31, 2005. Their survival status as of May 31, 2006 was ascertained through the Norwegian National Registry. Survival in PCI and CABG cohorts was compared using Cox regression and propensity analysis.
Results:
. Covariate adjusted survival was significantly improved by CABG compared to PCI in patients with three vessel disease with and without diabetes, with hazard ratios of 0.40 and 0.61, respectively. The difference was of borderline significance in patients with one/two vessel disease with diabetes, and no difference in survival between the strategies in patients with one/two vessel disease without diabetes. Propensity analysis supported these observations. Improved survival for the PCI cohort was observed in the last quintile of procedure times.
Conclusions:
Patients with three vessel disease with or without diabetes seem to have a survival benefit with CABG compared to PCI treatment.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
